MOLECULAR BIOLOGY OF HEPATITIS C VIRUS

丙型肝炎病毒的分子生物学

基本信息

项目摘要

Hepatitis C virus (HCV) is a major cause of community-acquired viral hepatitis. Prototype strains of the various genotypes of HCV, including some of those discovered in this laboratory, are being biologically amplified in chimpanzees, packaged and distributed for use as challenge inocula in studies of passive and active immunoprophylaxis, etc. Full-length cDNA clones of HCV (genotypes 1a, 1b and 2a) have been constructed and transcribed RNA used to transmit hepatitis C to chimpanzees by in vivo hepatic transfection. Chimpanzees, transfected with infectious cDNA clones of HCV, are being followed to determine the natural history of infection. Infectivity pools have been prepared from chimpanzees infected with monoclonal HCV (derived by in vivo transfection with RNA transcripts of infectious cDNA); these have been titered for infectivity in other chimpanzees. In addition, the availability of infectious cDNA clones of HCV has permitted for the first time a mutational analysis of genomic regions. For example, individual portions of the 3' NCR have been deleted from the full-length clone and the resultant deletion mutant clones inoculated into chimpanzees by intrahapatic transfection. Certain regions of the NCR have been identified as critical for in vivo replication of HCV. We have constructed an infectious cDNA clone of GB virus-B (GBV-B), a monkey virus that is the closest relative to HCV. In addition, we have prepared challenge pools of GBV-B and have determined the infectivity titer of these in tamarins. We plan to use the GBV-B tamarin system to study characteristics of the virus that it shares with HCV, which must be studied in chimpanzees. In other studies, we have constructed chimeric genomes from infectious cDNA clones of HCV and bovine viral diarrhea virus. These genomes can replicate in transfected cells but the resultant viral products cannot assemble into infectious virus in the absence of helper virus.We have determined the genetic heterogeneity of HCV isolates that were recovered from patients who were infected following transfusion. The sequence of the hypervariable region and adjacent portions of envelope proteins 1 and 2 were determined for multiple clones obtained from patients who had fulminant hepatitis, from patients who convalesced following acute hepatitis and from patients who progressed to chronic hepatitis C. Distinctive patterns of dynamic change in sequence of clones during the first several weeks of infection were observed. Patients with fulminant or resolving hepatitis had few changes in the sequences of clones, whereas there were many changes in the sequences of clones from patients who progressed to chronic hepatitis. Thus, the outcome of an HCV infection could be predicted in the first few weeks of the infection
丙型肝炎病毒(HCV)是社区获得性病毒肝炎的主要原因。 HCV各种基因型的原型菌株(包括在该实验室中发现的一些基因型)在黑猩猩中在生物学上放大,包装和分布在被动和主动免疫预防的研究中,以用作挑战接种。黑猩猩通过体内肝转染。正在遵循用感染性cDNA克隆转染的黑猩猩,以确定感染的自然病史。 感染性池是由感染单克隆HCV的黑猩猩制备的(通过体内转染,用感染性cDNA的RNA转录得出); 这些已被替代其他黑猩猩的感染性。此外,HCV的传染性cDNA克隆的可用性首次允许对基因组区域进行突变分析。 例如,3'NCR的各个部分已从全长克隆中删除,所得的缺失突变克隆通过缩写内转染接种到黑猩猩中。 NCR的某些区域已被确定为HCV体内复制至关重要。 我们已经构建了GB病毒-B(GBV-B)的传染性cDNA克隆,这是一种猴子病毒,是最接近HCV的猴子病毒。 此外,我们已经准备了GBV-B的挑战池,并确定了菜他蛋白中的感染性滴度。 我们计划使用GBV-B tamarin系统研究与HCV共享的病毒特征,必须在黑猩猩中研究。在其他研究中,我们从HCV和牛病毒腹泻病毒的传染性cDNA克隆中构建了嵌合基因组。 这些基因组可以在转染的细胞中复制,但是在没有辅助病毒的情况下,由此产生的病毒产物不能将其组装成传染性病毒。我们确定了从被感染后感染的患者中回收的HCV分离株的遗传异质性。 确定了从患有暴发性肝炎的患者获得的多个克隆,从急性肝炎后康复的患者以及从第一次感染序列的动态序列中获得独特的动态变化的患者,从患有暴发的肝炎的患者,从患有暴发的肝炎的患者中获得多个克隆的序列,并从患有肝炎的患者中获得了多个克隆的序列。 暴发或解决肝炎的患者的克隆序列几乎没有变化,而从发展为慢性肝炎的患者的克隆序列序列发生了许多变化。 因此,可以在感染的前几周预测HCV感染的结果

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Robert H. Purcell其他文献

Antibody to hepatitis A antigen in children
  • DOI:
    10.1016/s0022-3476(77)81317-6
    10.1016/s0022-3476(77)81317-6
  • 发表时间:
    1977-09-01
    1977-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Cladd E. Stevens;Charles E. Cherubin;Jules L. Dienstag;Robert H. Purcell;Wolf Szmuness
    Cladd E. Stevens;Charles E. Cherubin;Jules L. Dienstag;Robert H. Purcell;Wolf Szmuness
  • 通讯作者:
    Wolf Szmuness
    Wolf Szmuness
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen.
与肝炎相关抗原相关的物质在恒河猴中连续传播。
  • DOI:
    10.1093/infdis/125.4.382
    10.1093/infdis/125.4.382
  • 发表时间:
    1972
    1972
  • 期刊:
  • 影响因子:
    0
  • 作者:
    W. T. London;H. J. Alter;Jerrold Lander;Robert H. Purcell
    W. T. London;H. J. Alter;Jerrold Lander;Robert H. Purcell
  • 通讯作者:
    Robert H. Purcell
    Robert H. Purcell
Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants.
HGSAg 结构多肽抗体的表征:亚型特异性决定因素的证据。
  • DOI:
  • 发表时间:
    1976
    1976
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Jon W. M. Gold;J.W.K. Shih;Robert H. Purcell;J. Gerin
    Jon W. M. Gold;J.W.K. Shih;Robert H. Purcell;J. Gerin
  • 通讯作者:
    J. Gerin
    J. Gerin
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase.
编码衣壳蛋白和 RNA 聚合酶的甲型肝炎病毒 cDNA 的序列分析。
Acute viral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent.
沙特阿拉伯的急性病毒性肝炎:血清流行病学分析、危险因素、临床表现和第六种肝炎病原体的证据。
  • DOI:
  • 发表时间:
    1995
    1995
  • 期刊:
  • 影响因子:
    11.8
  • 作者:
    T. Ghabrah;G. T. Strickland;S. Tsarev;P. Yarbough;Patrizia Farci;R. Engle;S. Emerson;Robert H. Purcell
    T. Ghabrah;G. T. Strickland;S. Tsarev;P. Yarbough;Patrizia Farci;R. Engle;S. Emerson;Robert H. Purcell
  • 通讯作者:
    Robert H. Purcell
    Robert H. Purcell
共 10 条
  • 1
  • 2
前往

Robert H. Purcell的其他基金

Molecular Biology Of Hepatitis C Virus
丙型肝炎病毒的分子生物学
  • 批准号:
    6503690
    6503690
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Pathogenesis Of Viral Hepatitis
病毒性肝炎的发病机制
  • 批准号:
    6987075
    6987075
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    6985036
    6985036
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    8555744
    8555744
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    7592131
    7592131
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
New Approaches To Passive Immunoprophylaxis
被动免疫预防的新方法
  • 批准号:
    8336238
    8336238
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    8336037
    8336037
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    7299912
    7299912
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
Pathogenesis Of Enteric Viral Hepatitis
肠道病毒性肝炎的发病机制
  • 批准号:
    7964477
    7964477
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:
New Approaches To Passive Immunoprophylaxis
被动免疫预防的新方法
  • 批准号:
    7964628
    7964628
  • 财政年份:
  • 资助金额:
    --
    --
  • 项目类别:

相似海外基金

Human Reservoirs of Plasmodium vivax Transmission in the Peruvian Amazon
秘鲁亚马逊地区间日疟原虫传播的人类宿主
  • 批准号:
    7919067
    7919067
  • 财政年份:
    2009
  • 资助金额:
    --
    --
  • 项目类别:
Analytical and Morphological Core
分析和形态核心
  • 批准号:
    7249775
    7249775
  • 财政年份:
    2007
  • 资助金额:
    --
    --
  • 项目类别:
Human Reservoirs of Plasmodium vivax Transmission in the Peruvian Amazon
秘鲁亚马逊地区间日疟原虫传播的人类宿主
  • 批准号:
    7260464
    7260464
  • 财政年份:
    2006
  • 资助金额:
    --
    --
  • 项目类别:
Human Reservoirs of Plasmodium vivax Transmission in the Peruvian Amazon
秘鲁亚马逊地区间日疟原虫传播的人类宿主
  • 批准号:
    7635870
    7635870
  • 财政年份:
    2006
  • 资助金额:
    --
    --
  • 项目类别:
Human Reservoirs of Plasmodium vivax Transmission in the Peruvian Amazon
秘鲁亚马逊地区间日疟原虫传播的人类宿主
  • 批准号:
    7450837
    7450837
  • 财政年份:
    2006
  • 资助金额:
    --
    --
  • 项目类别: